ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,845Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 262

$602K Total Retail Price of All Prescriptions

Rank: 9 out of 262

647 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 647 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 647 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 7,003 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 483 393 1 1
AMLODIPINE BESYLATE 437 385 2 6
LISINOPRIL 354 304 3 3
FUROSEMIDE 348 303 4 4
LEVOTHYROXINE SODIUM 295 249 5 2
OMEPRAZOLE 291 198 6 5
CARVEDILOL 263 224 7 31
POTASSIUM CHLORIDE 236 197 8 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 226 187 9 24
HYDROCHLOROTHIAZIDE 206 188 10 7
METOPROLOL TARTRATE 198 181 11 8
CITALOPRAM HBR 189 151 12 20
METFORMIN HCL 182 151 13 9
WARFARIN SODIUM 154 141 14 12
ATORVASTATIN CALCIUM 137 88 15 13
METOPROLOL SUCCINATE 129 117 16 11
SERTRALINE HCL 115 98 17 14
ALLOPURINOL 107 97 18 22
HYDROCODONE-ACETAMINOPHEN 106 56 S3 19 15
ALENDRONATE SODIUM 96 82 20 21
GABAPENTIN 96 86 20 19
TRAMADOL HCL 94 56 22 18
LANTUS 76 46 23 51
PROAIR HFA 74 52 24 53
DONEPEZIL HCL 73 69 25 23
DILTIAZEM ER 68 68 26 75
CRESTOR 64 60 27 30
VENLAFAXINE HCL ER 62 50 28 79
LANTUS SOLOSTAR 62 53 28 49
SPIRONOLACTONE 61 48 30 58
SPIRIVA 58 55 31 61
PREDNISONE 52 49 32 29
ATENOLOL 52 45 32 16
OXYCODONE-ACETAMINOPHEN 51 48 S2 34 88
GLIPIZIDE 51 51 34 70
CELEBREX 51 50 34 91
TRIAMCINOLONE ACETONIDE 50 46 37 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.